China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Aberrantly Spliced Proteins in Liver Cancer: Systematic Functional Characterization and Evaluation of Their Potential for Drug Development'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135569
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350148
Published by HT Digital Content Services with permission from Health Daily Digest....